BPA exposure influences gut microbial diversity and childhood obesity risk

Patients with the genetic recessive disorder persistent chylomicronemia who received the investigational drug plozasiran had significantly lower triglyceride levels and a reduced risk of acute

As the biotech in­dus­try grap­ples with how to fund drug de­vel­op­ment in a world of in­creas­ing re­search costs, ris­ing drug prices and gov­ern­ment-re­lat­ed risk, a